The Approved Restructuring Provides Clarity, Responsibility and Accountability While Paving the Way to Long-term Success VANCOUVER, BC / September 28, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) announces that on September 26, 2018 the Board of Directors for CVR Medical Corp (CVM). held a Special Meeting of the Shareholders [...]
VANCOUVER, BC / August 23rd, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector announces that it intends to complete a non-brokered private placement financing (the "Financing") of units (each, a "Unit") for gross proceeds of up to [...]
Preliminary Analysis Demonstrates CSS Device Has To Date Exceeded Expectations for Specificity and Sensitivity Compared to Duplex Doppler Ultrasound VANCOUVER, BC / August 20th, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector announces advisory staff member Dr. Phillip [...]
VANCOUVER, BC / August 14th, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector has retained the services of Minneapolis-based medical device consulting firm, JD Lymon Group (www.jdlymon.com) to provide ongoing reimbursement guidance and to help support the company’s FDA [...]
VANCOUVER, BC / August 9th, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector has retained the services of NYC based Investor Relations Public Relations Firm ICR (www.icrinc.com) to support the company’s communications and marketing activities as it explores a [...]
VANCOUVER, BC / July 25, 2018 / CVR Medical Corp. CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) had entered into a letter agreement with Crystal Research Associates ("Crystal") dated September 25, 2017 (the "Letter Agreement") to compile an executive informational overview and quarterly updates on CVR Medical. Pursuant to the Letter Agreement, CVR [...]
Company To Explore US Capital Markets Up-Listing VANCOUVER, BC / June 7, 2018 / CVR Medical Corp. CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) announces it has exclusively retained ThinkEquity, a division of Fordham Financial Management, Inc., a NYC based, investment banking firm to explore listing onto a major exchange in the United States. [...]
Accord Lays Pathway for Long Term Success VANCOUVER, BC / May 29 2018 / CVR Medical Corp. CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) has reached agreement with joint venture partner CVR Global to acquire CVR Global’s 50% interest in the joint venture and terminate the joint venture (the "Transaction"). The Agreement [...]
VANCOUVER, BC / May 22 2018 / CVR Medical Corp. CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has retained BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on CVR Medical (OTCQB: CRRVF) (TSXV: CVM) (FSE: B3BN) after releasing [...]
VANCOUVER, BC / May 10 2018 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) announces Colonel Dallas C. Hack, MD, MPH, MSS, FACMPH, FS, CPE has been unanimously appointed to its Board of Directors, replacing Mr. Erwin Wong who is retiring. Colonel Hack is a brain injury expert and is board certified [...]
